Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine
Open Access
- 30 November 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (12), 6235-6242
- https://doi.org/10.1128/AAC.00602-12
Abstract
In vivo bacteriophage targeting of enteroaggregative Escherichia coli (EAEC) was assessed using a mouse intestinal model of colonization with the O104:H4 55989Str strain and a cocktail of three virulent bacteriophages. The colonization model was shown to mimic asymptomatic intestinal carriage found in humans. The addition of the cocktail to drinking water for 24 h strongly decreased ileal and weakly decreased fecal 55989Str concentrations in a dose-dependent manner. These decreases in ileal and fecal bacterial concentrations were only transient, since 55989Str concentrations returned to their original levels 3 days later. These transient decreases were independent of the mouse microbiota, as similar results were obtained with axenic mice. We studied the infectivity of each bacteriophage in the ileal and fecal environments and found that 55989Str bacteria in the mouse ileum were permissive to all three bacteriophages, whereas those in the feces were permissive to only one bacteriophage. Our results provide the first demonstration that bacterial permissivity to infection with virulent bacteriophages is not uniform throughout the gut; this highlights the need for a detailed characterization of the interactions between bacteria and bacteriophages in vivo for the further development of phage therapy targeting intestinal pathogens found in the gut of asymptomatic human carriers.This publication has 47 references indexed in Scilit:
- Shiga Toxin-Producing Escherichia coli O104:H4: a New Challenge for MicrobiologyApplied and Environmental Microbiology, 2012
- Origins of theE. coliStrain Causing an Outbreak of Hemolytic–Uremic Syndrome in GermanyNew England Journal of Medicine, 2011
- In Vivo and Ex Vivo Evaluations of Bacteriophages e11/2 and e4/1c for Use in the Control of Escherichia coli O157:H7Applied and Environmental Microbiology, 2010
- Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella InfectionInfection and Immunity, 2009
- The Pic Protease of Enteroaggregative Escherichia coli Promotes Intestinal Colonization and Growth in the Presence of MucinInfection and Immunity, 2009
- Role of Deoxyribose Catabolism in Colonization of the Murine Intestine by PathogenicEscherichia coliStrainsInfection and Immunity, 2009
- The Bacteria Fight BackScience, 2008
- Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound ModelAntimicrobial Agents and Chemotherapy, 2007
- Isolation and Characterization of a New T-Even Bacteriophage, CEV1, and Determination of Its Potential To Reduce Escherichia coli O157:H7 Levels in SheepApplied and Environmental Microbiology, 2006
- Application of Bacteriophages To Control Intestinal Escherichia coli O157:H7 Levels in RuminantsApplied and Environmental Microbiology, 2006